you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Aug 10, 16:01
4242.40 22.05 (0.52%)
Volume
AVERAGE VOLUME
5-Day
13,267
10-Day
34,919
30-Day
25,440
5,820
  • Prev. Close

    4220.35

  • Open Price

    4250.00

  • Bid Price (Qty.)

    4242.40 (10)

  • Offer Price (Qty.)

    4258.00 (2)

NSE Live

Aug 10, 15:57
4243.30 19.95 (0.47%)
Volume
AVERAGE VOLUME
5-Day
473,322
10-Day
623,532
30-Day
505,853
421,623
  • Prev. Close

    4223.35

  • Open Price

    4243.60

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    4243.30 (12)

Financials

2021 2020 2019 2018 2017
Half Yearly Results of Dr Reddys Laboratories (in Rs. Cr.) Mar '22 Sep '21 Mar '21 Sep '20 Mar '20  
Net Sales/Income from operations 7,111.50 7,256.90 6,758.90 6,570.40 5,881.90  
Other Operating Income 36.80 -- -- 19.80 13.80  
Total Income From Operations 7,148.30 7,256.90 6,758.90 6,590.20 5,895.70  
EXPENDITURE  
Consumption of Raw Materials 1,522.70 1,543.90 1,661.60 1,604.70 1,327.30  
Purchase of Traded Goods 1,089.20 1,279.70 647.70 604.60 572.20  
Increase/Decrease in Stocks -112.30 -277.30 -66.90 -328.70 -32.90  
Power & Fuel -- -- -- -- --  
Employees Cost 1,212.90 1,221.70 1,117.10 1,153.00 1,027.80  
Depreciation 410.60 403.70 423.10 411.90 388.10  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses 1,085.50 2,178.70 -- 1,799.30 --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies 9.80 -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,056.60 -- 2,022.50 -- 1,724.80  
P/L Before Other 873.30 906.50 953.80 1,345.40 888.40  
Other Income 177.70 304.30 144.40 659.30 196.70  
P/L Before Int. 1,051.00 1,210.80 1,098.20 2,004.70 1,085.10  
Interest 20.40 17.60 23.40 23.30 23.50  
P/L Before Exceptional Items & Tax 1,030.60 1,193.20 1,074.80 1,981.40 1,061.60  
Exceptional Items -- -- -- -- --  
P/L Before Tax 1,030.60 1,193.20 1,074.80 1,981.40 1,061.60  
Tax 269.80 330.80 319.60 550.20 37.10  
P/L After Tax from Ordinary Activities 760.80 862.40 755.20 1,431.20 1,024.50  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 760.80 862.40 755.20 1,431.20 1,024.50  
Equity Share Capital 83.20 83.20 83.20 83.10 83.10  
Reserves Excluding Revaluation Reserves -- 17.38 -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 45.72 52.01 45.38 86.31 61.64  
Diluted EPS -- 51.87 -- 86.08 --  
EPS After Extra Ordinary  
Basic EPS. 45.72 52.01 45.38 86.31 61.64  
Diluted EPS. -- 51.87 -- 86.08 --  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited